Tg Therapeutics (TGTX) FCF Margin Growth (1y) (2018 - 2026)
Tg Therapeutics (TGTX) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Tg Therapeutics | 8.08 Bn | 8.00 Bn | 171.41 Mn | 1,502.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,502.00 |
| Dec 31, 2025 | 3,389.00 |
| Sep 30, 2025 | 21.00 |
| Jun 30, 2025 | -230.00 |
| Mar 31, 2025 | -1,085.00 |
| Dec 31, 2024 | 632.00 |
| Sep 30, 2024 | -6,506.00 |
| Jun 30, 2024 | 26,886.00 |
| Mar 31, 2024 | 75,475.00 |
| Dec 31, 2023 | 2.98 Mn |
| Sep 30, 2023 | 3.68 Mn |
| Jun 30, 2023 | 800,736.00 |
| Mar 31, 2023 | 263,986.00 |
| Dec 31, 2022 | -2.61 Mn |
| Sep 30, 2022 | -3.34 Mn |
| Jun 30, 2022 | -436,293.00 |
| Mar 31, 2022 | 686,005.00 |
| Dec 31, 2021 | 13.36 Mn |
| Sep 30, 2021 | 14.57 Mn |
| Jun 30, 2021 | 11.16 Mn |